CICERO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 8.600
EU - Europa 3.119
AS - Asia 1.535
SA - Sud America 245
AF - Africa 40
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.567
Nazione #
US - Stati Uniti d'America 8.566
IT - Italia 936
CN - Cina 701
FI - Finlandia 604
SG - Singapore 523
DE - Germania 428
UA - Ucraina 253
GB - Regno Unito 216
BR - Brasile 209
IE - Irlanda 207
SE - Svezia 104
RU - Federazione Russa 101
IN - India 60
BE - Belgio 53
RO - Romania 53
FR - Francia 50
TR - Turchia 44
KR - Corea 28
NL - Olanda 28
IR - Iran 22
AT - Austria 20
MY - Malesia 19
CI - Costa d'Avorio 18
ES - Italia 18
AU - Australia 17
HK - Hong Kong 17
PH - Filippine 17
CA - Canada 16
UZ - Uzbekistan 15
IQ - Iraq 12
PL - Polonia 12
MX - Messico 11
AR - Argentina 10
JP - Giappone 10
IL - Israele 9
MA - Marocco 7
PY - Paraguay 7
TW - Taiwan 7
EU - Europa 6
ID - Indonesia 6
VE - Venezuela 6
CH - Svizzera 5
CO - Colombia 5
LB - Libano 5
NO - Norvegia 5
SA - Arabia Saudita 5
VN - Vietnam 5
ZA - Sudafrica 5
CL - Cile 4
EC - Ecuador 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
SD - Sudan 4
BG - Bulgaria 3
DK - Danimarca 3
PK - Pakistan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
LT - Lituania 2
MM - Myanmar 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BT - Bhutan 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.567
Città #
Fairfield 1.374
Ashburn 807
Woodbridge 746
Chandler 696
Wilmington 552
Seattle 550
Houston 548
Ann Arbor 525
Cambridge 479
Singapore 364
Palermo 249
Dublin 202
Medford 167
Jacksonville 128
Altamura 116
Nanjing 109
Des Moines 108
Princeton 103
Lawrence 90
Santa Clara 90
San Diego 78
Dearborn 70
New York 69
Hefei 62
The Dalles 58
Boardman 56
Beijing 55
Brussels 51
Changsha 50
Shenyang 49
Tulsa 49
Milan 47
Council Bluffs 39
Ludwigshafen am Rhein 39
Nanchang 36
Hebei 33
Jinan 32
London 32
Bremen 31
Rome 30
Kumar 29
Jiaxing 28
Zhengzhou 27
Tianjin 26
Helsinki 25
Izmir 25
Nuremberg 24
Redwood City 23
Los Angeles 22
Phoenix 22
Falls Church 20
Munich 20
Ningbo 20
Berlin 19
Saint Petersburg 19
Chicago 18
Guangzhou 18
Seongnam 18
Abidjan 17
Frankfurt am Main 17
Verona 15
Auburn Hills 14
São Paulo 14
Hangzhou 13
Pune 13
San Paolo di Civitate 13
Tehran 13
Venice 13
Kitzingen 11
Taizhou 11
Valenzuela 11
Lanzhou 10
Turin 10
Amsterdam 9
Belo Horizonte 9
Redmond 9
Shanghai 9
Tashkent 9
Toronto 9
Moscow 8
Rio de Janeiro 8
Taiyuan 8
Vienna 8
Aversa 7
Edinburgh 7
Indiana 7
Orange 7
Tokyo 7
Washington 7
Hong Kong 6
La Jolla 6
Aldeatejada 5
Columbus 5
Düsseldorf 5
Falkenstein 5
Forest City 5
Haikou 5
Islington 5
Istanbul 5
Kilburn 5
Totale 9.752
Nome #
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 225
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 224
Psychological distress and quality of life in ostomy patients with colorectal cancer: A systematic review of the literature 223
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 219
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 209
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 208
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 206
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 203
Whatsapp messenger as a tool for the multidisciplinary management in everyday clinical practice 202
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 200
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy 199
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 196
A headlight on liquid biopsies: a challenging tool for breast cancer management 191
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 190
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study 183
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy 181
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 180
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 180
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 179
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 178
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 176
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 174
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 173
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 169
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 168
Targeted Therapies in Hepatocellular Carcinoma 168
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 168
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 167
HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY 166
Monoclonal antibodies in gastrointestinal cancers 164
Primary Non-Hodgkin’s lymphoma of the parotid gland 163
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 163
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 162
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. 161
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 160
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer 160
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 159
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 157
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 156
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 154
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 153
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 153
Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life 153
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. 151
The patient-physician relationship in the face of oncological disease: A review of literature on the emotional and psychological reactions of patients and physician 150
Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status 149
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 147
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? 144
Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials? 140
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer 139
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 138
Circulating exosomal Hsp60 as a new marker of colon cancer. 137
Vg9Vd2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies 137
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 137
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 136
Well-being among Italian medical oncologists: An exploratory study 135
The Role of Couples' Attachment Styles in Patients' Adjustment to Cancer 135
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 130
Aminobisphosphonates as New Weapons for gammaDelta T Cell-Based Immunotherapy of Cancer 124
Studio di fase II con Taxotere + Doxorubicina liposomiale + Trastuzumab nel trattamento del carcinoma mammario metastatico c-erb-B2 positivo 123
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 123
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 123
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 123
Geldanamycin and its derivatives as Hsp90 inhibitors 123
Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer 123
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience 122
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 121
The clinical efficacy of enzalutamide in metastatic prostate cancer: Prospective single-center study 121
Studio pilota sul valore predittivo dei livelli plasmatici di 9 fattori angiogenetici nella selezione di pazienti candidati alla biopsia prostatica 119
Does Exist A Correlation Between BMI and Gleason Patterns 4 and 5 At Prostate Biopsy? 118
Bortezomib: a new pro-apoptotic agent in cancer treatment. 117
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 116
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population 116
Role of densitometric criteria in evaluation of effectiveness of antiangiogenic therapies in metastatic colorectal cancer: An Italian clinical experience 110
Ramucirumab and its use in gastric cancer treatment 109
Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an italian clinical axperience 107
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 106
Impact of combination chemotherapy on toxicity in ovarian cancer: Systematic revision of literature and meta-analysis 106
A rare case of extra-intramedullary dorsal tanycitic ependymoma, radically removed with intraoperative neurophysiological monitoring 100
Emergenze metaboliche 99
Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients 96
Studio di fase II con Gemcitabine + Oxaliplatino in combinazione nel trattamento delle neoplasie delle vie biliari, pancreas e colecisti in fase metastatica. 95
Unusual case of dorsal vertebral metastases from a male breast cancer 95
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 94
Heterogeneity and prognostic influence of tumor- infiltrating γδ T lymphocytes in colon cancer patients 89
Cardiotossicità e Cardioprotezione. 85
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vc9Vd2 T Cell-Mediated Cytotoxicity 77
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 76
Leptin plasma levels in patients undergoing prostate biopsy. a preliminary study in 50 patients 74
Correlation between leptin plasmatic levels in non-obese patients and detection rate at prostate biopsy”- Poster P147 74
Tas-102 in metastatic colorectal cancer (MCRC): Efficacy, tolerability, and quality of life in heavily pretreated elderly patients: A real-life study 74
Evaluation of anxiety level in patients wating to undergo to diagnostic radiological exams 71
Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel: A retrospective study 69
Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen 67
La terapia adiuvante nel carcinoma del colon: un update della lettaratura 63
Terapia medica e supporto psicologico in un gruppo di pazienti affette da carcinoma mammario 63
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study 60
CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY 60
Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): Efficacy, tolerability and Quality of Life 58
NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: A real-life study 50
Totale 13.867
Categoria #
all - tutte 53.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020564 0 0 0 0 0 0 0 0 0 194 278 92
2020/20211.606 108 108 133 143 101 73 101 123 193 203 150 170
2021/20221.542 70 310 65 98 78 73 91 108 158 130 129 232
2022/20231.932 198 384 38 237 217 265 84 157 194 11 99 48
2023/2024898 35 107 60 68 58 165 80 111 7 28 42 137
2024/20251.553 49 176 233 173 104 87 160 189 135 247 0 0
Totale 14.150